FR2423218A1 - Composition pharmaceutique a base de dipropionate de beclomethasone - Google Patents

Composition pharmaceutique a base de dipropionate de beclomethasone

Info

Publication number
FR2423218A1
FR2423218A1 FR7833744A FR7833744A FR2423218A1 FR 2423218 A1 FR2423218 A1 FR 2423218A1 FR 7833744 A FR7833744 A FR 7833744A FR 7833744 A FR7833744 A FR 7833744A FR 2423218 A1 FR2423218 A1 FR 2423218A1
Authority
FR
France
Prior art keywords
beclomethasone dipropionate
pharmaceutical composition
composition based
relates
pulverulent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7833744A
Other languages
English (en)
Other versions
FR2423218B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2423218A1 publication Critical patent/FR2423218A1/fr
Application granted granted Critical
Publication of FR2423218B1 publication Critical patent/FR2423218B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne l'industrie pharmaceutique. Elle a pour objet une composition pharmaceutique comprenant un mélange de dipropionate de béclométhasone particulaire, les particules de dipropionate de béclométhasone ayant pour au moins 90 % en poids une granulométrie effective de moins de 10 microns, et d'un véhicule pulvérulent, de préférence en l'absence de tout liquide. Ces compositions sont préférées pour le traitement de certaines affections respiratoires, comme l'asthme et le rhume des foins.
FR7833744A 1977-11-30 1978-11-29 Composition pharmaceutique a base de dipropionate de beclomethasone Granted FR2423218A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB49759/77A GB1571629A (en) 1977-11-30 1977-11-30 Pharmaceutical compositions containing beclomethasone dipropionate

Publications (2)

Publication Number Publication Date
FR2423218A1 true FR2423218A1 (fr) 1979-11-16
FR2423218B1 FR2423218B1 (fr) 1984-05-25

Family

ID=10453448

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7833744A Granted FR2423218A1 (fr) 1977-11-30 1978-11-29 Composition pharmaceutique a base de dipropionate de beclomethasone

Country Status (7)

Country Link
US (1) US4199578A (fr)
JP (1) JPS5484022A (fr)
AU (1) AU525470B2 (fr)
BE (1) BE872319A (fr)
DE (1) DE2851489A1 (fr)
FR (1) FR2423218A1 (fr)
GB (1) GB1571629A (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IT1212896B (it) * 1983-11-08 1989-11-30 Della Valle Francesco Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
FR2651678B1 (fr) * 1989-09-08 1992-04-30 Glaxo Group Ltd Composition pharmaceutique a base de salmeterol et de dipropionate de beclometasone.
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9603725D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New teatment
US6380222B2 (en) 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
EP0876814A1 (fr) * 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Exipient pour inhalateur à poudre sèche, procédé de sa préparation et compositions pharmaceutiques la contenant
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US6551578B2 (en) * 2001-02-15 2003-04-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
CA2562585A1 (fr) 2004-04-23 2005-11-10 Cydex, Inc. Formulation pour inhalateurs a poudre seche contenant de la cyclodextrine d'ether de sulfoalkyle
EP1848444B1 (fr) 2005-02-10 2016-11-09 Glaxo Group Limited Procedes de fabrication du lactose au moyen de techniques de pre-classification et preparations pharmaceutiques ainsi obtenues
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937303A (en) * 1959-01-02 1963-09-18 Benger Lab Ltd Improvements in and relating to the application of drugs in finely divided condition
FR2143163A2 (fr) * 1971-06-22 1973-02-02 Fisons Ltd
LU67462A1 (fr) * 1972-04-20 1973-07-05
US4039668A (en) * 1973-06-23 1977-08-02 Schering Aktiengesellschaft Corticoid-containing inhalants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1440064A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd Delta8-9- steroids of the pregnane series

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937303A (en) * 1959-01-02 1963-09-18 Benger Lab Ltd Improvements in and relating to the application of drugs in finely divided condition
FR2143163A2 (fr) * 1971-06-22 1973-02-02 Fisons Ltd
LU67462A1 (fr) * 1972-04-20 1973-07-05
US4039668A (en) * 1973-06-23 1977-08-02 Schering Aktiengesellschaft Corticoid-containing inhalants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE MERCK INDEX, édition 9, 1976, Merck & Co. Inc. (RAHWAY, N.J., US), abrégé 206 "Albuterol", abrégé 5782 "Metaproterenol", abrégé 8879 "Terbutaline", pages 30, 772 et 1180 *

Also Published As

Publication number Publication date
GB1571629A (en) 1980-07-16
FR2423218B1 (fr) 1984-05-25
DE2851489A1 (de) 1979-05-31
AU525470B2 (en) 1982-11-11
AU4210078A (en) 1979-06-07
BE872319A (fr) 1979-05-28
JPS5484022A (en) 1979-07-04
US4199578A (en) 1980-04-22

Similar Documents

Publication Publication Date Title
FR2423218A1 (fr) Composition pharmaceutique a base de dipropionate de beclomethasone
AU654813B2 (en) The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
DE69306755T2 (de) Verbessertes verfahren zur herstellung von mikronisierter polypeptidarzneimitteln
EE03222B1 (et) Inhaleeritavad ravimpreparaadid, protsess nende valmistamiseks ja seade nende kasutamiseks
ES2123576T3 (es) Medicamentos.
BE875217A (fr) Nouvelles oximes 0-substituees de l'acide 7-amino thiazolyl acetamido cephalosporanque, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2504408B1 (fr) Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
ATE152630T1 (de) Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
KR970704422A (ko) 투여용 약제학적 조성물
EP0536204A1 (fr) Emploi de tensio-actifs fluores solubles dans la preparation de compositions pour aerosol doseur.
ATE133423T1 (de) Rekonstituierte hdl-teilchen und ihre verwendung
PT91852A (pt) Processo para a preparacao de produtos contendo psyllium
EP1345591A1 (fr) Preparation pharmaceutique en aerosol
Zenz et al. Acute vanadium pentoxide intoxication
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
AP2000001837A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs.
DZ1779A1 (fr) Procédé pour la préparation de particules préparées à sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules.
WO2000001392B1 (fr) 1-octadecyl-2-methyl-sn-glycero-3-phosphocholine (et180ch3) pour traiter les cancers du sein humains
LU81156A1 (fr) Nouvelles oximes derivees de l'acide 3-azidomethyl 7-amino thiazolyl acetamido cephalosporanique,leur procede de preparation,leur application comme medicaments et les compositions pharmaceutiques les renfermant
ES8707197A1 (es) Un procedimiento para preparar derivados de tioimidazol
FR2426460A1 (fr) Composition antiallergique
BE875560A (fr) Nouvelles oximes derivees de l'acide 3-azidomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
ES405567A1 (es) Un metodo para la obtencion de un preparado farmaceutico a-decuado para el tratamiento y profilaxis de estados tales como asma extrinseco o fiebre del heno.
ES413624A3 (es) Un metodo para preparar una composicion farmaceutica en polvo facilmente fluidizable, prevista especialmente para eltratamiento por inhalacion de enfermedades alergicas de las vias respiratorias.
Tanahashi et al. Dangerous Drugs analysis survey in Aichi Prefecture

Legal Events

Date Code Title Description
ST Notification of lapse